The American Diabetes Association (ADA) is inviting nominations for the Pathway to Stop Diabetes initiative, which supports innovative basic, clinical, translational, epidemiological, behavioral, or health services research relevant to any diabetes type, diabetes-related disease state, or diabetes complication. The Association seeks exceptional candidates from a broad range of disciplines, including medicine, biology, chemistry, computing, physics, mathematics and engineering.
Each institution is allowed a maximum of one nomination. The nomination can be in one of the three available Pathway award types (please click on the hyperlinks for each program type’s detail):
- Initiator – For researchers in postdoctoral training
- Accelerator – For early-career diabetes investigators
- Visionary – For established investigators, new to diabetes research
Pathway awards provide up to $1.625 million per award in combined salary and project support. The Association expects to support between four and six applicants from the 2016 award competition, with grants commencing in January 2017.
Since UCI may submit only one proposal across all 3 categories, interested applicants (or their nominator) are asked to submit a preliminary application to the Office of Research by April 25, 2016 (via the UCI Review application portal), with the following information:
- Clearly state which award type the applicant is applying for
- Brief proposal (up to three pages)
- The proposal should outline the applicant’s research strategy as well as his/her capacity for innovation, creativity and collaboration. Please reference the ADA Pathway general review criteria, to ensure each component is adequately addressed.
- Bio sketch (no more than two pages) of the primary researcher
- Support Letter either Authored or Endorsed by the Dean (or equivalent)
Please note: If more than one application from any one school is submitted, the Dean will be asked to rank them.
If necessary, an ad hoc committee will convene to review the preliminary proposals. The selected PI will be notified in time to develop their full application and meet the ADA nomination deadline of July 1, 2016.
For the complete guidelines, please refer to http://professional.diabetes.org/meetings/call-nominations. Questions about our internal campus review process may be directed to Greg Ruth at firstname.lastname@example.org or x4-0372.
**Please circulate this message where appropriate as not all eligible candidates (e.g. PostDocs eligible for the “Initiator” awards) are receiving this email.**
James W. Hicks
Interim Vice Chancellor for Research
Professor of Biology